ipamorelin clinicaltrials gov CJC-1295 (no DAC), 10mg (Blend) Side Effects IPAMORELIN – Research Peptide |

Most research protocols use one or the other based on study objectives, not both simultaneously

The molecule retains the complete 70-amino-acid native IGF-1 sequence with two structural modifications a 13-amino-acid N-terminal extension (the Long designation) and an arginine-for-glutamic-acid substitution at position 3 (the R3 designation) which together reduce binding affinity to circulating IGF binding proteins (IGFBPs) by approximately 600-fold while preserving full agonist activity at the IGF-1 receptor

CJC-1295 sustains elevated baseline GH through prolonged GHRH receptor engagement

When used with Tesamorelin, these benefits can be enhanced

Along with pro-inflammatory circulating signals, a transcription factor, NF- B, is a product of chronic inflammation in cardiovascular tissue and is a useful clinical indicator for obesity-related inflammation (de Almeida et al., 2020)